CDH1 and neoplasm: A study of E-cadherin levels by immunohistochemistry in nonmalignant and malignant specimens of human prostatic tissue revealed that almost 50% of tumours examined had reduced levels of this protein, and in some tumours E-cadherin was absent altogether when compared to non-malignant prostate, which uniformly stained strongly positive [83].